STEINERT

Clinical trials for STEINERT explained in plain language.

Never miss a new study

Get alerted when new STEINERT trials appear

Sign up with your email to follow new studies for STEINERT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Hope for muscle disease: new drug enters final testing phase

Disease control Ongoing

This study tests a new medicine called AOC 1001 for people with myotonic dystrophy type 1, a genetic disease that causes muscle weakness and stiffness. About 159 adults with a confirmed diagnosis will receive either the drug or a placebo by IV. The main goal is to see if the drug…

Matched conditions: STEINERT

Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control

Last updated May 14, 2026 12:02 UTC

STEINERT

Get alerted when new STEINERT trials appear

Hope for muscle disease: new drug enters final testing phase